Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 1997Antimicrobial Agents and ChemotherapyOpen Access

Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp

View Full Paper
Ask AI
Bookmark
Share

Authors

DLD. LawLinköping UniversityCMCaroline B. MooreManchester Academic Health Science Centre
David W. Denning
David W. DenningStatens Serum Institut

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Law et al. (1997) studied this question.

synapsesocial.com/papers/6a82398af2e4e6540e2a50ffhttps://doi.org/10.1128/aac.41.10.2310
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five <i>Candida species</i>1995 · 36 citations
  2. 2Emergence of azole drug resistance in <i>Candida</i> species from HIV-infected patients receivingprolonged fluconazole therapy for oral candidosis1995 · 256 citations
  3. 3High prevalence of antifungal resistance in <i>Candida</i> spp. from patients with AIDS1994 · 139 citations
  4. 4Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain1995 · 35 citations
  5. 5In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts1997 · 83 citations